Mounjaro (Tirzepatide) Programs
Physician-guided tirzepatide programmes for diabetes and weight loss.
Mounjaro (tirzepatide) in India is a prescription medicine that acts on two gut hormones, GIP and GLP-1, to lower blood sugar and support significant weight loss. At EDFC, Mounjaro is used only under physician guidance, with careful dose steps and monitoring.
What is Mounjaro (tirzepatide)?
Tirzepatide is a once-weekly injection that improves how the body handles sugar after meals and reduces appetite. Because it targets two hormone pathways rather than one, trials have shown strong effects on both blood sugar and weight. It is a newer option within the GLP-1 class of therapies.
Who can consider Mounjaro?
Mounjaro is prescription only and suits selected adults with type 2 diabetes or obesity related risk, decided after a full assessment. It is not suitable in some conditions, and our team reviews your history first. Mild nausea early on is common and usually eases. The World Health Organization links reducing excess weight to lower diabetes and heart risk.
Why choose EDFC for Mounjaro in India?
Our team handles dosing, side effect support and follow up, and links your progress to HbA1c monitoring and body composition. Compare it with our Ozempic and Wegovy programme, or see all advanced therapies. Book a review with our clinic team. This page is educational and not a substitute for a consultation.